YC and Alchemist-backed Segmed Raises $5.2M Funding Round and Launches Medical Real World Imaging Platform
PR98824
PALO ALTO, Calif., Nov. 16, 2022 /PRNewswire=KYODO JBN/ --
Segmed - a cloud-based real-world imaging platform that accelerates innovation
in healthcare by simplifying access to medical data - announced the closing of
a $5.2 million seed+ funding round led by Nina Capital, with participation from
iGan Partners, M3 Inc, Mighty Capital, Expeditions Fund, and Alchemist
Accelerator, bringing total funds raised to more than $10 million. The company
also reported the launch of Segmed Insight.
Logo - https://mma.prnewswire.com/media/1346461/Segmed_Logo.jpg
Segmed Insight was built with the goal of getting high-quality, real-world
medical imaging datasets in the hands of clinicians, researchers and
developers; particularly those seeking to train or validate their AI algorithms.
Medical researchers and AI developers using Segmed Insight can conduct a
search, view studies and reports matching their search criteria, and construct
datasets specific to their parameters. After placing an order, users receive
data in hand within days - a process that took years prior to Segmed.
By forging partnerships with healthcare systems, hospitals and imaging clinics
across 1,000 locations on 5 continents, Segmed has done the heavy lifting when
it comes to aggregating diverse medical data.
Patient privacy and data stewardship remain paramount at Segmed. The company
maintains strict HIPAA/GDPR compliance, obtained its SOC2 attestation this
year, and only shares fully de-identified data, ensuring that no personal
information is exposed.
"The healthcare industry has become increasingly adoptive of artificial
intelligence methods, but a roadblock in the development of unbiased,
high-performing algorithms has been the timely acquisition of diverse,
high-quality data," said Dr. Martin Willemink, CEO and co-founder at Segmed.
"With Insight, our customers can massively cut down on data sourcing time,
which in turn accelerates research and development in the medical field."
"Segmed is well positioned to lower the barriers for innovation in medical AI
by bridging the gap between data providers and data consumers," said Sebastian
Anastassiou, Head of Investments at Nina Capital. "This will make it easier to
tackle tough healthcare problems, ultimately improving the quality of patient
care in years to come."
"We are excited to be supporting Segmed in their latest raise – we believe that
the company is on a growth trajectory to becoming one of the leading AI data
platforms in the healthcare industry. They have real time access to
machine-readable data with a focus on medical imaging, which is an invaluable
type of data for healthcare. With this round, iGan is looking forward to
working with Martin and the team to drive outbound partnerships and expand key
features of the platform." said Sam Ifergan, Managing Partner at iGan Partners.
About Segmed
By partnering with global healthcare providers; standardizing and
de-identifying data via a sequence of proprietary algorithms; and allowing
users to build customized datasets, Segmed has become a one-stop-shop for rapid
medical data aggregation. To learn more, visit segmed.ai [
] or get started at join.segmed.ai [
].
SOURCE: Segmed
CONTACT: rachel@segmed.ai
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。